These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Low-dose danazol therapy in idiopathic thrombocytopenic purpura].
    Author: Nozaki H, Tanaka K, Yonekura S, Shimizu M, Komatsuda M, Nagao T, Arimori S.
    Journal: Rinsho Ketsueki; 1990 Oct; 31(10):1750-1. PubMed ID: 2255068.
    Abstract:
    Danazol was administered orally at a dosage of 50 mg/day to 17 patients (11 females and 6 males) with idiopathic thrombocytopenic purpura refractory to steroids and/or splenectomy. The patients had not been treated with conventional dosages of danazol. The drug was suspended in four patients because of adverse effects of danazol. In 13 patients (8 females and 5 males, mean age 44 y. o.) who received the danazol therapy for more than 6 months, there were no patients with an excellent response, and one patient had a good response to the therapy. The rest of the patients did not respond to danazol.
    [Abstract] [Full Text] [Related] [New Search]